NCT04868786View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

July 31, 2025

Study Completion Date

October 31, 2025

Conditions
Hematopoietic Stem Cell Transplantation
Interventions
DRUG

Mycophenolate Mofetil

Administer 15-20mg/kg of mycophenolate mofetil twice daily. Blood sampling for pharmacokinetics(PK) of mycophenolate mofetil will be performed in all patients who have taken the investigational drug for at least 3 days.

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

National Institute of Food and Drug Safety Evaluation (Republic of Korea)

UNKNOWN

lead

Seoul National University Hospital

OTHER